As of Nov 27
| -0.05 / -0.48%|
The 5 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 31.00 and a low estimate of 13.00. The median estimate represents a +52.96% increase from the last price of 10.46.
The current consensus among 7 polled investment analysts is to Hold stock in Aegerion Pharmaceuticals Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.